Logo Image
News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtablesShorts
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

CAROLINE T. STORK, PHD

Advertisement

Articles by CAROLINE T. STORK, PHD

Implications of the 21st Century Cures Act on Antibiotic Drug Development

ByALLISON KOMIRENKO, PHARMD,CAROLINE T. STORK, PHD,JOHN MOHR, PHARMD,HELEN W. BOUCHER, MD
May 8th 2017

Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.

Advertisement

Latest Updated Articles

  • Implications of the 21st Century Cures Act on Antibiotic Drug Development
    Implications of the 21st Century Cures Act on Antibiotic Drug Development

    May 8th 2017



Advertisement
Advertisement

Trending on Contagion Live

1

Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311

2

ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections

3

The HIV Testing Gap and What Clinicians Can Do About It

4

Once-Weekly HIV Pill Meets Phase 3 Endpoints, Advancing Potential First Long-Acting Oral Treatment

5

When Fever in Infants is Invasive Bacterial Infection

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us